EUVIMEDEUVIMED entdecken
Open Access

Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation

Wenliang Zhu iD, Wan Du iD, Arun Prabhu Rameshbabu iD, Ariel Miura Armstrong iD, Stewart Silver iD, Yehree Kim iD, Wei Wei iD, Yilai Shu iD, Xuezhong Liu, Morag A Lewis iD, Karen P Steel iD, Zheng-Yi Chen iD

Science Translational Medicine · 10.07.2024 · 16 (755)

DOI: 10.1126/scitranslmed.adn0689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 10.07.2024. Verfasst von Wenliang Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Graduate Program in Speech and Hearing Bioscience and Technology and Program in Neuroscience, Har…. Hauptthemen laut MEDLINE: MicroRNAs, Gene Editing, Mutation, Hearing Loss. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCD NIH HHS, NHGRI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in microRNA-96 ( MIR96 ) cause autosomal dominant deafness-50 (DFNA50), a form of delayed-onset hearing loss. Genome editing has shown efficacy in hearing recovery through intervention in neonatal mice, yet editing in the adult inner ear is necessary for clinical applications, which has not been done. Here, we developed a genome editing therapy for the MIR96 mutation 14C>A by screening different CRISPR systems and optimizing Cas9 expression and the sgRNA scaffold for efficient and specific mutation editing. AAV delivery of the KKH variant of Staphylococcus aureus Cas9 (SaCas9-KKH) and sgRNA to the cochleae of presymptomatic (3-week-old) and symptomatic (6-week-old) adult Mir96 14C>A/+ mutant mice improved hearing long term, with efficacy increased by injection at a younger age. Adult inner ear delivery resulted in transient Cas9 expression without evidence of AAV genomic integration, indicating the good safety profile of our in vivo genome editing strategy. We developed a dual-AAV system, including an AAV-sgmiR96-master carrying sgRNAs against all known human MIR96 mutations. Because mouse and human MIR96 sequences share 100% homology, our approach and sgRNA selection for efficient and specific hair cell editing for long-term hearing recovery lay the foundation for the development of treatment for patients with DFNA50 caused by MIR96 mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsGene EditingMutationHearing LossDependovirusAnimalsHumansMiceCRISPR-Cas SystemsCochleaGenetic TherapyRNA, Guide, CRISPR-Cas SystemsBase SequenceHearing

Substanzen

MicroRNAsMirn96 microRNA, mouseRNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Graduate Program in Speech and Hearing Bioscience and Technology and Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA.
  • Eaton-Peabody Laboratory, Massachusetts Eye and Ear, Boston, MA 02114, USA.
  • ENT Institute and Otorhinolaryngology Department of Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200031, China.
  • Institutes of Biomedical Science, Fudan University, Shanghai 200032, China.
  • NHC Key Laboratory of Hearing Medicine, Fudan University, Shanghai 200031, China.
  • Department of Otolaryngology, University of Miami School of Medicine, Miami, FL 33136, USA.

ORCID-Profile: Wenliang Zhu, Wan Du, Arun Prabhu Rameshbabu, Ariel Miura Armstrong, Stewart Silver, Yehree Kim, Wei Wei, Yilai Shu, Morag A Lewis, Karen P Steel, Zheng-Yi Chen

Förderung

  • NIDCD NIH HHS
  • NHGRI NIH HHS
  • NCATS NIH HHS
  • Wellcome Trust

Zitieren

APA

Zhu, W., Du, W., Rameshbabu, A. P., Armstrong, A. M., Silver, S., Kim, Y., Wei, W., Shu, Y., Liu, X., Lewis, M. A., Steel, K. P., & Chen, Z. Y. (2024). Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation. Science Translational Medicine, 16(755). https://doi.org/10.1126/scitranslmed.adn0689

Vancouver

Zhu W, Du W, Rameshbabu AP, Armstrong AM, Silver S, Kim Y, et al. Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation. Science Translational Medicine. 2024;16(755). doi:10.1126/scitranslmed.adn0689

BibTeX
@article{Zhu2024,
  author = {Zhu, Wenliang and Du, Wan and Rameshbabu, Arun Prabhu and Armstrong, Ariel Miura and Silver, Stewart and Kim, Yehree and Wei, Wei and Shu, Yilai and Liu, Xuezhong and Lewis, Morag A and Steel, Karen P and Chen, Zheng-Yi},
  title = {Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation},
  journal = {Science Translational Medicine},
  year = {2024},
  volume = {16},
  number = {755},
  doi = {10.1126/scitranslmed.adn0689}
}
Kostenlos starten →